For patients without a breast cancer diagnosis, receiving second-opinion interpretations of breast imaging exams relieve anxiety while reducing patient morbidity and healthcare costs, according to a study published May 19 in the Journal of the American College of Radiology.

Reuters reports HCA’s proposal would essentially reverse Envision’s 2016 merger with AmSurg. The rest of the $5.1 billion Envision would be taken over by KKR.

UnitedHealth said it costs an average of $9,400 annually to cover a low-income, subsidized enrollee on the marketplace with $7,000 of that cost falling on the federal government. For someone eligible for Medicaid thanks to the Affordable Care Act (ACA), the overall cost is $5,400—with $5,100 coming from federal funds.

Direct federal funding for abortions has been prohibited by Congress for decades, but conservative lawmakers have sought to deny all federal funding to groups like Planned Parenthood for having any involvement in abortion services.

Three sponsors of Medicare Part D plans—UnitedHealth Group, Humana and CVS Health—account for more than half the program’s total enrollment. If proposed mergers involving smaller players like Aetna, Express Scripts and Cigna move ahead, the market would become even more concentrated.

Could Illinois become the 36th state that requires mammography providers to notify patients when it is determined they have dense breast tissue?

Vermont has become the first state to pass a law to allow prescription drugs to be imported from Canada, but the plan still has to be approved by HHS—a tall order considering HHS Secretary Alex Azar’s comments that pharmaceutical imports are a “gimmick” and may be unsafe.

Kyle Pitsor, vice president of government affairs for the National Electrical Manufacturers Association (NEMA), testified this week about the potential impact tariffs proposed by the Office of the United States Trade Representative (USTR) could have on NEMA member companies and the electrical and medical imaging industries.